metronidazole has been researched along with clotrimazole in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (25.00) | 18.7374 |
1990's | 5 (13.89) | 18.2507 |
2000's | 11 (30.56) | 29.6817 |
2010's | 10 (27.78) | 24.3611 |
2020's | 1 (2.78) | 2.80 |
Authors | Studies |
---|---|
Hall, SS; Loebenberg, D; Schumacher, DP | 1 |
Abraham, MH; Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Ekins, S; Harwood, HJ; Hoover, DJ; Lawton, MP; Mankowski, DC; Treadway, JL | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Chandrasekaran, B; Cherukupalli, S; Hampannavar, GA; Karpoormath, R; Palakollu, VN; Thapliyal, N | 1 |
Lövgren, T; Salmela, I | 1 |
Adler, MW; O'Connor, BH | 1 |
Holt, RJ | 1 |
Daujat, M; Domergue, J; Fabre, I; Joyeux, H; Maurel, P; Maurice, M; Pichard, L | 1 |
Landers, DV | 1 |
Małyszko, E; Niczyporuk, W; Roszkiewicz, J; Szarmach, H; Wroński, A | 1 |
Dickins, CS; Krieger, JN; Rein, MF | 1 |
Schnell, JD | 1 |
Döring, HF; Ilgner, M | 1 |
Baron, JR; Kelly, RB | 1 |
Boldrini, E; Campora, U; Debbia, EA; Massaro, S; Schito, GC | 1 |
Danzig, MR; duBouchet, L; McCormack, WM; Rein, MF; Spence, MR | 1 |
Jalsenjak, I; Pavelić, Z; Skalko-Basnet, N | 2 |
Estcourt, C; Lomax, NJ; Mirakian, R | 1 |
Czeizel, AE; Fladung, B; Vargha, P | 1 |
Mammen-Tobin, A; Wilson, JD | 1 |
Chanana, C; Mittal, S; Raina, U; Sharma, JB | 1 |
Agyarko-Poku, T; Asamoah-Adu, C; Deslandes, S; Diakité, S; Frost, E; Khonde, N; Labbé, AC; Pépin, J; Sobela, F; Sylla, M | 1 |
Bornstein, J; Zarfati, D | 1 |
Ahmad, FJ; Alam, MA; Ali, M; Khan, ZI; Khar, RK | 1 |
Barrio, AG; Escribano, AI; García-Trevijano, JA; Marcel, AM; Redó, VJ; Ruiz, JJ; Tugores, YM | 1 |
Mattana, P; Tavassoli, K | 1 |
Bao, L; Li, W; Li, Y; Wang, Y; Xu, J; Yin, M; Yu, X; Zhao, Z; Zhu, C | 1 |
Cianci, A; Corsello, S; Ettore, G; Genovese, C; Mattana, P; Tempera, G | 1 |
Balasubramaniam, R; Beneragama, H; Navaratinaraja, TS; Sri Ranganathan, S | 1 |
5 review(s) available for metronidazole and clotrimazole
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold.
Topics: Animals; Chemistry Techniques, Synthetic; Humans; Pyrazoles; Pyrimidines | 2017 |
The treatment of vaginitis: Trichomonas, yeast, and bacterial vaginosis.
Topics: Antifungal Agents; Bacterial Infections; Candidiasis, Vulvovaginal; Clotrimazole; Drug Administration Schedule; Female; Humans; Metronidazole; Miconazole; Nystatin; Trichomonas Vaginitis; Vaginitis | 1988 |
Selections from current literature: issues in the management of vaginitis.
Topics: Candidiasis, Vulvovaginal; Chronic Disease; Clotrimazole; Female; Humans; Male; Metronidazole; Recurrence; Sexual Partners; Vaginosis, Bacterial; Yogurt | 1993 |
Combined systemic (fluconazole) and topical (metronidazole + clotrimazole) therapy for a new approach to the treatment and prophylaxis of recurrent candidiasis.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Drug Therapy, Combination; Female; Fluconazole; Humans; Metronidazole; Probiotics; Recurrence | 2019 |
5 trial(s) available for metronidazole and clotrimazole
Article | Year |
---|---|
The incidence of vaginal candida and trichomonas infections and treatment of trichomonas vaginitis with clotrimazole.
Topics: Adult; Aged; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Female; Humans; Imidazoles; Metronidazole; Middle Aged; Trichomonas Vaginitis | 1974 |
Multicenter comparison of clotrimazole vaginal tablets, oral metronidazole, and vaginal suppositories containing sulfanilamide, aminacrine hydrochloride, and allantoin in the treatment of symptomatic trichomoniasis.
Topics: Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Allantoin; Aminacrine; Antitrichomonal Agents; Clotrimazole; Female; Humans; Metronidazole; Middle Aged; Sulfanilamide; Sulfanilamides; Trichomonas Vaginitis | 1997 |
Comparative efficacy of two regimens in syndromic management of lower genital infections.
Topics: Administration, Intravaginal; Adult; Anti-Infective Agents, Local; Azithromycin; Clotrimazole; Drug Therapy, Combination; Female; Fluconazole; Humans; Metronidazole; Pruritus; Vaginitis | 2006 |
The syndromic management of vaginal discharge using single-dose treatments: a randomized controlled trial in West Africa.
Topics: Adolescent; Adult; Africa, Western; Animals; Anti-Infective Agents; Antifungal Agents; Antitrichomonal Agents; Candida; Child; Clotrimazole; Drug Therapy, Combination; Female; Fluconazole; Humans; Metronidazole; Mycoplasma genitalium; Neisseria gonorrhoeae; Sex Work; Syndrome; Tinidazole; Treatment Outcome; Trichomonas vaginalis; Vaginal Discharge | 2006 |
A universal combination treatment for vaginitis.
Topics: Administration, Intravaginal; Adult; Anti-Infective Agents; Clotrimazole; Double-Blind Method; Drug Combinations; Female; Humans; Metronidazole; Vaginitis | 2008 |
26 other study(ies) available for metronidazole and clotrimazole
Article | Year |
---|---|
Structure-activity relationships of synthetic antibiotic analogues of anisomycin.
Topics: Animals; Anisomycin; Bacteria; Entamoeba; Fungi; Pyrrolidines; Structure-Activity Relationship; Trichomonas | 1983 |
ElogPoct: a tool for lipophilicity determination in drug discovery.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Solvents | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors.
Topics: Amides; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Humans; Indoles; Models, Molecular; Oxidoreductases; Quantitative Structure-Activity Relationship; Sterol 14-Demethylase | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
In vitro sensitivity of Trichomonas vaginalis and Candida albicans to chemotherapeutic agents.
Topics: Antifungal Agents; Antitrichomonal Agents; Candida albicans; Chlorquinaldol; Clotrimazole; Hydroxyquinolines; Metronidazole; Natamycin; Nystatin; Oxyquinoline; Tinidazole; Trichomonas vaginalis | 1978 |
Current approaches to the diagnosis, treatment, and reporting of trichomoniasis and candidosis.
Topics: Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Male; Medical Records; Metronidazole; Nystatin; Trichomonas Vaginitis | 1979 |
New antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Chlorobenzenes; Clotrimazole; Flucytosine; Humans; Imidazoles; Mebendazole; Metronidazole; Miconazole; Mycoses; Thiabendazole; Tinidazole | 1975 |
Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture.
Topics: Blotting, Northern; Cells, Cultured; Clotrimazole; Cytochrome P-450 Enzyme System; Fluconazole; Humans; Imidazoles; Kinetics; Liver; Metronidazole; Miconazole; Microsomes, Liver; Mixed Function Oxygenases; RNA; RNA, Messenger | 1992 |
[Mixed infections of the urogenital tract with Trichomonas vaginalis and yeast-like fungi in humans with reference to treatment].
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Drug Administration Schedule; Female; Humans; Male; Metronidazole; Tinidazole; Trichomonas Vaginitis | 1986 |
Use of a time-kill technique for susceptibility testing of Trichomonas vaginalis.
Topics: 4-Quinolones; Anti-Infective Agents; Anti-Infective Agents, Urinary; Clotrimazole; Female; Humans; Kinetics; Metronidazole; Microbial Sensitivity Tests; Quinolines; Quinolones; Time Factors; Trichomonas vaginalis | 1985 |
[Local treatment of rosacea with imidazole derivatives].
Topics: Administration, Topical; Adult; Aged; Clotrimazole; Econazole; Female; Humans; Imidazoles; Male; Metronidazole; Miconazole; Middle Aged; Rosacea | 1983 |
In vitro activity of metronidazole alone and in combination with clotrimazole against clinical isolates of Trichomonas vaginalis.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antitrichomonal Agents; Clotrimazole; Drug Resistance, Microbial; Drug Therapy, Combination; In Vitro Techniques; Metronidazole; Trichomonas vaginalis | 1996 |
Liposomes containing drugs for treatment of vaginal infections.
Topics: Administration, Intravaginal; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Cattle; Chloramphenicol; Clotrimazole; Drug Carriers; Drug Delivery Systems; Female; Hydrogen-Ion Concentration; Liposomes; Metronidazole; Mycoplasma Infections; Phosphatidylcholines; Vaginosis, Bacterial | 1999 |
Symptomatic trichomoniasis, metronidazole allergic and pregnant--a management dilemma.
Topics: Adult; Animals; Anti-Infective Agents, Local; Antitrichomonal Agents; Clotrimazole; Drug Hypersensitivity; Female; Humans; Metronidazole; Pessaries; Pregnancy; Pregnancy Complications, Parasitic; Trichomonas Vaginitis | 2004 |
Preterm birth reduction after clotrimazole treatment during pregnancy.
Topics: Administration, Intravaginal; Adolescent; Adult; Anti-Infective Agents; Anti-Infective Agents, Local; Case-Control Studies; Child; Clotrimazole; Confounding Factors, Epidemiologic; Drug Interactions; Female; Gestational Age; Humans; Hungary; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Metronidazole; Pregnancy; Premature Birth; Prevalence; Retrospective Studies; Treatment Outcome | 2004 |
Management of metronidazole-resistant Trichomonas vaginalis--a new approach.
Topics: Ampicillin; Animals; Antitrichomonal Agents; Clotrimazole; Doxycycline; Drug Resistance; Drug Therapy, Combination; Female; Humans; Metronidazole; Retrospective Studies; Tinidazole; Treatment Outcome; Trichomonas vaginalis; Trichomonas Vaginitis | 2005 |
Characterisation and in vitro evaluation of bioadhesive liposome gels for local therapy of vaginitis.
Topics: Acrylates; Administration, Intravaginal; Antifungal Agents; Clotrimazole; Drug Compounding; Drug Stability; Drug Storage; Excipients; Female; Gels; Humans; Liposomes; Metronidazole; Particle Size; Tissue Adhesives; Vaginitis; Viscosity | 2005 |
Development and evaluation of acid-buffering bioadhesive vaginal tablet for mixed vaginal infections.
Topics: Acrylic Resins; Adhesiveness; Animals; Antifungal Agents; Antiprotozoal Agents; Buffers; Candida albicans; Carboxymethylcellulose Sodium; Chemistry, Pharmaceutical; Citrates; Clotrimazole; Drug Combinations; Drug Compounding; Excipients; Female; Humans; Hydrogen-Ion Concentration; Kinetics; Lactobacillus acidophilus; Membranes, Artificial; Metronidazole; Mucous Membrane; Probiotics; Reproducibility of Results; Sodium Citrate; Solubility; Tablets; Technology, Pharmaceutical; Vaginitis | 2007 |
Validation of a modified fluorimetric assay for the screening of trichomonacidal drugs.
Topics: Antitrichomonal Agents; Clotrimazole; Fluorometry; High-Throughput Screening Assays; Metronidazole; Oxazines; Parasitic Sensitivity Tests; Sensitivity and Specificity; Trichomonas vaginalis; Xanthenes | 2012 |
[Topical treatment of vaginal infections by the association of metronidazole-clotrimazole].
Topics: Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Metronidazole; Vaginosis, Bacterial | 2013 |
Acute vanishing bile duct syndrome after therapy with cephalosporin, metronidazole, and clotrimazole: A case report.
Topics: Adult; Anti-Bacterial Agents; Bile Duct Diseases; Bile Ducts, Intrahepatic; Cephalosporins; Clotrimazole; Drug Therapy, Combination; Female; Humans; Metronidazole; Syndrome | 2017 |
Price and affordability of key essential medicines for children in Sri Lanka, a lower-middle-income country: comparison of two national cross-sectional surveys done 8 years apart.
Topics: Amoxicillin; Child; Chlorpheniramine; Clotrimazole; Cross-Sectional Studies; Developing Countries; Drugs, Essential; Drugs, Generic; Humans; Mebendazole; Metronidazole; Sri Lanka | 2023 |